112 related articles for article (PubMed ID: 38058839)
21. Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience.
Yen HH; Chen CN; Yeh CC; Lai IR
World J Surg Oncol; 2021 Apr; 19(1):124. PubMed ID: 33865416
[TBL] [Abstract][Full Text] [Related]
22. The effect of Mitomycin-C in neoadjuvant concurrent chemoradiotherapy for rectal cancer.
Wang LW; Liu YS; Jiang JK
J Chin Med Assoc; 2022 Dec; 85(12):1120-1125. PubMed ID: 36194168
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
24. T-status and an oral fluoropyrimidine, S-1, adjuvant chemotherapy are prognostic factors in reduced-RADPLAT for resectable hypopharyngeal cancer.
Wakisaka N; Hirai N; Kondo S; Aga M; Nakanishi Y; Tsuji A; Endo K; Murono S; Yoshizaki T
Acta Otolaryngol; 2016 Aug; 136(8):834-40. PubMed ID: 27007816
[TBL] [Abstract][Full Text] [Related]
25. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.
Turan N; Benekli M; Unal OU; Unek İT; Tastekin D; Dane F; Algın E; Ulger S; Eren T; Topcu TO; Turkmen E; Babacan NA; Tufan G; Urakci Z; Ustaalioglu BO; Uysal OS; Ercelep OB; Taskoylu BY; Aksoy A; Canhoroz M; Demirci U; Dogan E; Berk V; Balakan O; Ekinci AŞ; Uysal M; Petekkaya İ; Ozturk SC; Tonyalı Ö; Çetin B; Aldemir MN; Helvacı K; Ozdemir N; Oztop İ; Coskun U; Uner A; Ozet A; Buyukberber S;
Chin J Cancer Res; 2015 Aug; 27(4):408-16. PubMed ID: 26361410
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
Hasegawa K; Saiura A; Takayama T; Miyagawa S; Yamamoto J; Ijichi M; Teruya M; Yoshimi F; Kawasaki S; Koyama H; Oba M; Takahashi M; Mizunuma N; Matsuyama Y; Watanabe T; Makuuchi M; Kokudo N
PLoS One; 2016; 11(9):e0162400. PubMed ID: 27588959
[TBL] [Abstract][Full Text] [Related]
27. Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.
Yeh YS; Tsai HL; Huang CW; Wei PL; Sung YC; Tang HC; Wang JY
Trials; 2017 Apr; 18(1):191. PubMed ID: 28441966
[TBL] [Abstract][Full Text] [Related]
28. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
29. Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
Soh J; Toyooka S; Okumura N; Nakamura H; Nakata M; Yamashita M; Sakamoto J; Aoe M; Hotta K; Morita S; Date H
Int J Clin Oncol; 2019 Nov; 24(11):1367-1376. PubMed ID: 31312931
[TBL] [Abstract][Full Text] [Related]
30. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial Cancer Recurrence].
Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant chemotherapy can prolong recurrence-free survival but did not influence the type of recurrence or subsequent treatment in patients with colorectal liver metastases.
Kokudo T; Saiura A; Takayama T; Miyagawa S; Yamamoto J; Ijichi M; Teruya M; Yoshimi F; Kawasaki S; Koyama H; Oba M; Takahashi M; Mizunuma N; Matsuyama Y; Ishihara S; Makuuchi M; Kokudo N; Hasegawa K
Surgery; 2021 Oct; 170(4):1151-1154. PubMed ID: 34030885
[TBL] [Abstract][Full Text] [Related]
32. Cortactin as a potential predictor of second esophageal neoplasia in hypopharyngeal carcinoma.
Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA
Auris Nasus Larynx; 2019 Apr; 46(2):260-266. PubMed ID: 30107961
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer.
Nishimura A; Yokota T; Hamauchi S; Onozawa Y; Notsu A; Sato F; Kawakami T; Ogawa H; Onoe T; Mukaigawa T
BMC Cancer; 2022 Oct; 22(1):1101. PubMed ID: 36303119
[TBL] [Abstract][Full Text] [Related]
34. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.
Kwong DL; Sham JS; Au GK; Chua DT; Kwong PW; Cheng AC; Wu PM; Law MW; Kwok CC; Yau CC; Wan KY; Chan RT; Choy DD
J Clin Oncol; 2004 Jul; 22(13):2643-53. PubMed ID: 15226332
[TBL] [Abstract][Full Text] [Related]
35. Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Liang SK; Wu CW; Chang CI; Keng LT; Lee MR; Wang JY; Ko JC; Liao WY; Chen KY; Ho CC; Shih JY; Yu CJ
Cancer Med; 2023 Sep; 12(17):17993-18004. PubMed ID: 37559409
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy improves long-term survival in pathologic stage III rectal mucinous adenocarcinoma after pre-operative chemoradiotherapy.
Liao H; Li T; Liang Y; Liu Y; Yuan Y; Li M; Li A; Liu Y; Yao Y; Li T
Int J Colorectal Dis; 2023 Aug; 38(1):207. PubMed ID: 37542591
[TBL] [Abstract][Full Text] [Related]
37. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
[TBL] [Abstract][Full Text] [Related]
38. miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial.
Khan K; Cunningham D; Peckitt C; Barton S; Tait D; Hawkins M; Watkins D; Starling N; Rao S; Begum R; Thomas J; Oates J; Guzzardo V; Fassan M; Braconi C; Chau I
Oncotarget; 2016 Mar; 7(11):12672-81. PubMed ID: 26862857
[TBL] [Abstract][Full Text] [Related]
39. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
40. A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.
Chen YM; Perng RP; Tsai CM; Whang-Peng J
Lung Cancer; 2006 Jun; 52(3):333-8. PubMed ID: 16554106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
